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Background: Nicotine is associated with increased incidence of periodontal disease 
and poor response to therapy. This article aimed at identifying the expression 
of matrix metalloproteinases 2 (MMPs2) and vascular endothelial growth factor 
(VEGF) proteins on extracellular matrix, fibrous distribution and angiogenetic de-
velopment in periodontitis caused by nicotine effects on periodontal membrane. 
Materials and methods: In this experimental study, rats were divided into nicotine 
and control groups. While the rats in the nicotine group (n = 6) were admini-
stered 2 mg/kg nicotine sulphate for 28 days, the animals in the control group 
(n = 6) were only administered 1.5 mL physiologic saline solution subcutaneously 
for 28 days. 
Results: Histological sections were prepared and immunohistochemically stained 
for MMP2 and VEGF. The sections stained with Trichrome-Masson were observed 
under light microscope. VEGF and MMP2 immunoreactivity of periodontal gingiva 
and dentin was assessed by immunohistochemical staining. 
Conclusions: Nicotine reduces MMP production, disrupts collagen synthesis 
and causes periodontitis. We observed that nicotine increases periodontitis by 
disrupting periodontal membrane and prevents tooth to anchor in dental alveoli 
by disrupting epithelial structure. (Folia Morphol 2018; 77, 3: 471–477)
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INTRODUCTION
Periodontal disease is one of the major dental 
pathologies that affect human populations world-
wide at high prevalence rates. Periodontitis is a mul-
tifactorial disease that involves microbial challenge 
and host responses. Although bacteria are the initial 
factors for human periodontitis, their impact may be 
modified by an individual’s predisposition, which can 
determine the manifestation and progression of the 
disease [11]. Matrix metalloproteinases (MMPs) play 
an important role in physiological and pathological 
events, including the repair and breakdown of con-
nective tissue because of the inflammatory response 
[20]. Excessive production of MMP2 because of ge-
netic polymorphisms may influence the manifestation 
and development of periodontal diseases [28]. The 
underlying mechanisms causing these pathological 
conditions are still unclear. Two mechanisms were 
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proposed to explain this progression: bacteria acquire 
the ability to penetrate the deeper tissues [16], and/or 
the host response is degraded [3]. In particular, resident 
periodontal ligament and gingival fibroblasts have been 
reported to secrete MMPs and chemoattractants for 
epithelial cells [14]. Different proteoglycans and glycosa-
minoglycans, such as syndecan 1, also seem to play an 
important role in the inflammation during periodontal 
disease [1, 25]. The progression of inflammation and 
periodontal destruction requires a response to a bacte-
rial insult; that includes resident cells that sustain signals 
to trigger the immune response. Host-derived cytokines 
released upon microbial challenge have significant ef-
fects on the immune and inflammatory responses in 
periodontal disease [12, 37]. 
Previous studies have demonstrated that daily 
injection of nicotine causes significantly heavier al-
veolar part resorption in rats than injection of saline 
[8, 30]. Compared with non-smoking periodontitis, 
the height and density of alveolar part in the peri-
odontal tissue of smoking-associated periodontitis is 
lower, and closely related to smoking dose and time 
[29]. MMP2 plays a pivotal role in remodelling base-
ment membranes via pericellular and cell-attachment 
proteins [33, 36, 41]. Vascular endothelial growth 
factor (VEGF) has been reported to stimulate en-
dothelial cell proliferation, which plays a key role 
in the regulation of physiological and pathological 
angiogenesis, thereby affecting angiogenesis and 
increasing vascular permeability [24]. This protein 
seems to be involved in the onset and progression 
of gingivitis and periodontitis, mainly by promoting 
the vascular network expansion generally observed 
in inflammation [22]. Studies intended to associate 
the action of VEGF with the pathogens of periodontal 
disease have reported controversial findings. Never-
theless, VEGF expression is more strongly related to 
the healing stage of periodontal disease than to the 
destruction stage of the lesion [10].
The purpose of this study is to investigate the effects 
of MMP2 and VEGF proteins on extracellular matrix, 
fibrous distribution and angiogenetic development in 
periodontitis caused by nicotine effect on periodontal 
membrane and alveolar part of mandible.
MATERIALS AND METHODS
Animals and experimental design
All procedures performed in this experiment were 
approved by the Ethics Committee for the Treatment of 
Experimental Animals (Faculty of Medicine, University of 
Dicle, Turkey). Twelve Wistar male rats (180–250 g) were 
maintained under 22 ± 1°C and 12 h light/dark cycles 
with ad libitum access to standard pelleted food and 
water. The rats were divided into two groups: nicotine 
group and control group. The rats of the nicotine group 
(n = 6) were nicotinised systemically with nicotine 
sulphate (Sigma, Aldrich), 2 mg/kg subcutaneously, 
daily for 28 days. The rats of the control group (n = 6) 
were used as control and only administered 1.5 mL 
physiologic saline solution subcutaneously for 28 days. 
The rats of the control group were maintained in same 
environment and food as the experimental group. All 
rats at the end of experiment were healthy and no dif-
ference in food/water consumption and body weight 
gain between experimental and control rats were ob-
served. At the end of the study, the animals were sacri-
ficed using a decapitator (Harvard Apparatus, Holliston, 
MA, USA). The body of mandible (alveolar part) was 
dissected under ketamine hydrochloride anaesthesia. 
Alveolar part (pars alveolaris) was removed with mo-
lar tooth backward from the lower incisor tooth. The 
samples were fixed with neutral buffered 10% formalin 
solution and decalcified with 5% ethylenediamine-
tetraacetic acid (EDTA). After preservation, alveolar 
part samples were directly dehydrated in a graded 
series of ethanol and embedded into paraffin wax. 
Five mm sections were cut with microtome (Rotatory 
Microtome, Leica, RM 2265, Germany) and mounted 
on the coated slides. The sections were stained with 
Trichrome-Masson in order to be observed under light 
microscope.
Immunohistochemical staining 
Antigen retrieval process was performed in citrate 
buffer solution (pH: 6.0) two times: boiled in micro-
wave oven at 700 W first for 6 min, and then for 
4 min. They were allowed to cool to room temperature 
for 20 min and washed two times in distilled water for 
4 min. Endogenous peroxidase activity was blocked 
in 0.1% hydrogen peroxide for 10 min. Ultra V block 
(Histostain-Plus Kit, Invitrogen, Carlsbad, CA) was ap-
plied for 8 min prior to the application of primary an-
tibodies: MMP2 antibody, mouse monoclonal, 1/100, 
Santa Cruz and VEGF antibody, mouse monoclonal, 
1/100, Santa Cruz for overnight. Secondary antibody 
(Histostain-Plus Kit, Invitrogen, Carlsbad, CA) was 
applied for 20 min. Then, slides were exposed to 
streptavidin-peroxidase for 25 min. Diaminobenzidine 
(DAB, Invitrogen, Carlsbad) was used as a chromogen. 
Control slides were prepared as mentioned above but 
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omitting the primary antibodies. After counterstain-
ing with haematoxylin, washing in tap water for 
4 min and in distilled water for 2 × 4 min, the slides 
were mounted.
Statistical analysis
Statistical analysis was performed with the Sta-
tistical Package for the Social Sciences for Windows 
(version 15.0, SPSS Inc., Chicago, IL, USA). The Mann-
Whitney U test was used for the statistics as indicated. 
The results were expressed as mean ± standard devia-
tion. P values below 0.05 were considered to indicate 
statistical significant.
RESULTS
The histopathological results of the present study 
were evaluated under light microscope. There were 
no histopathological changes in control group. We 
compared periodontal membrane and alveolar part 
of mandible between control and nicotine groups 
(Table 1).
Collagen fibres were parallelly dispersed through-
out alveolar part of mandible, fibroblasts were in 
fusiform shape and their nuclei were centrally located. 
Dilated blood vessels and haemorrhage, mononuclear 
cell infiltration around vessels, hyperplasic fibroblast 
cells, increased number of inflammatory cells be-
tween alveolar part of mandible and periodontal 
membrane were observed in nicotine group. In the 
control group, there were no histological changes in 
the vascular endothelial cells and connective tissue 
of junction in where periodontal gingiva and alveolar 
part intersect. Positive VEGF expression was observed. 
In the nicotine group, elevated VEGF expression was 
observed in the endothelial cells of dilated vessels. In 
addition, inflammatory cells around collagen fibres 
showed increased VEGF expression. In the control 
group, MMP2 was also expressed in collagen fibres of 
periodontal gingiva and dentin, and tissue of alveolar 
part of mandible. In the nicotine group, MMP2 ex-
pression was weak in alveolar part and collagen fibres 
of tooth root region while it was strong in inflamed 
Table 1. Comparison of nicotine and control groups in terms of matrix metalloproteinases 2 (MMPs2) and vascular endothelial growth 
factor (VEGF) expression and histopathological features
Control (n = 6)  
(mean ± standard deviation) 
Nicotine (n = 6)  
(mean ± standard deviation)
P
Dilatation and haemorrhage in blood vessels 0.01 ± 0.03 4.0 ± 0.0 ≤ 0.001
Mononuclear cells infiltration 0.23 ± 0.41 2.63 ± 0.20 < 0.01
Damage of collagen fibres 0.0 ± 0.0 1.80 ± 0.20 ≤ 0.001
VEGF expression 1.53 ± 0.5 4.53 ± 0.61 < 0.001
MMP2 expression 3.62 ± 0.3 0.82 ± 0.4 < 0.01
A
Figure 1. A. Control group: regular distribution of fibroblasts in collagen fibres. Trichrom Masson, bar 100 µm; B. Nicotine group: dilatation 
and haemorrhage in blood vessel (arrow), mononuclear cell infiltration around vessels, hyperplasia in fibroblast cells, an increase in  
inflammatory cells between alveolar part of mandible and periodontal membrane (arrow), Trichrom Masson, bar 50 µm,
B
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Figure 2. A, B. Control group: positive vascular endothelial growth factor (VEGF) expression in vascular endothelial cells in the gingival, 
periodontal membrane and alveolar junction (arrow), VEGF immune staining; bar 100 µm; C, D. Nicotine group: an increase in positive VEGF 
expression in vascular endothelial cells and inflammatory cells (arrow), VEGF immune staining; bar 50 µm.
cells. MMP2 expression was particularly positive in 
basal membrane of blood vessels (Figs. 1–3). 
DISCUSSION
Periodontal disease encompassing both gingivitis 
and periodontitis is a host-mediated inflammatory 
process initiated by oral bacterial insult, which may 
result in significant alterations in the normal structure 
and/or function of the supporting tissues of the denti-
tion. Although colonisation of host tissues by patho-
genic organisms is the initiating factor in this disease 
process, the associated rate of progression and de-
gree of destruction are dependent upon both the 
virulence of the invading organisms and the magni-
tude/persistence of the host response. Treatment of 
periodontal diseases has a great deal in common with 
the treatment of infectious diseases elsewhere in the 
body by controlling the putative pathogens. The goal 
of periodontal therapy is the elimination or reduction 
of periodontal pathogens from the oral cavity and the 
subgingival area response to this infection. And, one 
of the important factors is tobacco smoking, which 
is associated with aggravated periodontal tissue de-
struction, pocket formation, alveolar part (the body 
of mandible or maxilla) resorption in periodontitis 
[5, 18, 21, 39, 40]. 
Pathogenic pathways involved in the imbalance of 
connective tissue homeostasis in periodontal inflam-
matory diseases are complex, and specific mediation 
is not completely understood. Activation of MMPs is 
one of the most important evolving under a rigorous 
control. MMPs are zinc-dependent proteases that 
break down extracellular matrix molecules, including 
dermal collagen and elastin. The proteolytic activity 
of MMPs has been reported to be inhibited by tissue 
inhibitors of metalloproteinases [23]. Nicotine has 
been reported to up-regulate MMP-1, MMP-2 and 
MMP-3 gene expression in arterial smooth muscle 
cells [9]. Cigarette smoke condensate has been re-
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gene expression in vascular endothelial cells [34]. 
Faruk et al. [13] found that fibroblast metabolism 
could be altered by nicotine action and intercellular 
matrix synthesis was affected. It also affects periodon-
tal ligament fibroblasts and stimulates osteoclasts 
activity [19, 42]. In our study, nicotine administra-
tion caused a change in fibroblast activity due to 
the change of collagen fibre synthesis and decreased 
MMP2 expression. Several MMPs have been identified 
in the inflamed gingival tissues: MMP-1, -2, -3, -8, -9, 
-13, produced by the keratinocytes, macrophages, 
polymorphonuclear leukocytes [2, 3, 6, 26, 27]. Their 
activity could be different depending on the sever-
ity of disease and the needs for extracellular matrix 
digestion. In some cases, MMP-1 expression extended 
to the lamina propria as inflammation progressed. 
Increased activity of MMP-1 could explain the change 
of collagen quality and quantity, since its preferred 
substrates are the type I and type III collagens. Several 
other researchers reported an intense collagenolytic 
activity of MMP-1 in fibroblasts and macrophages 
resident in the periodontal tissue [4, 26] and focused 
on the interrelation between MMP-1 and MMP-3 in 
amplifying the proteolysis in chronic periodontitis [4]. 
The balance between MMPs and tissue inhibitors 
of metalloproteinases influence on extracellular ma-
trix homeostasis in different types of tissues is tightly 
controlled by growth factors, a class of polypeptide 
hormones. One of the most important growth fac-
tors is VEGF. Over the last two decades researchers 
have demonstrated that VEGF is a key regulator of 
physiological and pathological angiogenesis, because 
it induces endothelial cell proliferation, stimulates 
angiogenesis and increases vascular permeability. 
VEGF immunoreactivity was observed in vascular en-
dothelial cells, osteoblasts, osteoclasts in resorption 
lacunae, in fibroblasts adjacent to hyalinised tissue, 
a local necrotic area in compressed zone, and in mon-
onuclear cells in periodontal tissues from the animals 
[32]. Growth factors mediate many events associated 
Figure 3. A, B. Control group: matrix metalloproteinase 2 (MMP2) expression at periodontal gingiva, and alveolar bone inter-sections, MMP2 
immune staining; bar 100 µm; C, D. Nicotine group: MMP2 expression in collagen fibres is weak in dental alveoli, alveolar part of mandible 
and collagen fibres in periodontal membrane, MMP2 expression is positive in basal membranes of blood vessels (red arrow), MMP2 immune 
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with turnover, repair and regeneration of periodontal 
tissues. Gingival epithelial cells, gingival fibroblasts, 
and periodontal ligament fibroblasts are the major 
cells involved in tissue repair. An appropriate response 
of these target cells to various growth factors de-
pends on the expression of corresponding receptors. 
Studies have demonstrated inhibition of proliferation, 
extracellular matrix production, and attachment of 
human gingival fibroblast, in addition to increased 
collagenase activity in the presence of nicotine [38]. 
In periodontitis patients, VEGF was detected within 
vascular endothelial cells, neutrophils, plasma cells, 
and junctional, pocket and gingival epithelium [7]. In 
a previous study on biopsies obtained from patients 
with type 2 diabetes-associated gingival overgrowth, 
we detected VEGF expression in keratinocytes from 
the basal and spinous layers and in many de novo 
capillaries [35]. Other authors reported increased 
VEGF expression in epithelial cells and endothelial 
cells in periodontitis-affected gingiva [17, 24, 31]. 
Giannobile et al. [15] suggested that VEGF could be 
an important growth factor for the onset of gingivitis 
and its progression to periodontitis.  
CONCLUSIONS
On the basis of our findings, increased angio-
genic activity with increased VEGF production was 
observed in endothelial cells in the vessel wall of 
the nicotine-administered group. Our study showed 
that cell degeneration, inflammation and changes 
in ligaments with disorders in vascular structure all 
prevent tooth to bind to alveolar part and periodon-
tal gingiva. Increased amount of VEGF protein in 
endothelial cells induces angiogenesis. It is thought 
that the change of vessels location due to nicotine 
effect may promote endothelial cells to proliferation. 
Nicotine reduces MMP2 production, disrupts collagen 
synthesis and causes periodontitis. It is stated that 
nicotine increases periodontitis by disrupting peri-
odontal membrane and prevents teeth to anchor in 
dental alveoli by disrupting epithelial structure.  
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